176 related articles for article (PubMed ID: 8070858)
21. Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene.
Koc H; Tretyakova NY; Walker VE; Henderson RF; Swenberg JA
Chem Res Toxicol; 1999 Jul; 12(7):566-74. PubMed ID: 10409395
[TBL] [Abstract][Full Text] [Related]
22. Dosimetry of styrene 7,8-oxide in styrene- and styrene oxide-exposed mice and rats by quantification of haemoglobin adducts.
Osterman-Golkar S; Christakopoulos A; Zorcec V; Svensson K
Chem Biol Interact; 1995 Mar; 95(1-2):79-87. PubMed ID: 7697755
[TBL] [Abstract][Full Text] [Related]
23. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
Blair IA; Oe T; Kambouris S; Chaudhary AK
Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
[TBL] [Abstract][Full Text] [Related]
24. Interspecies differences in metabolism and kinetics of 1,3-butadiene, isobutene and styrene.
Bolt HM
IARC Sci Publ; 1993; (127):37-44. PubMed ID: 8070883
[TBL] [Abstract][Full Text] [Related]
25. Hemoglobin adducts and urinary mercapturic acids in rats as biological indicators of butadiene exposure.
Osterman-Golkar S; Kautiainen A; Bergmark E; Håkansson K; Mäki-Paakkanen J
Chem Biol Interact; 1991; 80(3):291-302. PubMed ID: 1954657
[TBL] [Abstract][Full Text] [Related]
26. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
27. DNA adducts in rats and mice following exposure to [4-14C]-1,2-epoxy-3-butene and to [2,3-14C]-1,3-butadiene.
Boogaard PJ; de Kloe KP; Booth ED; Watson WP
Chem Biol Interact; 2004 Jun; 148(1-2):69-92. PubMed ID: 15223358
[TBL] [Abstract][Full Text] [Related]
28. NTP Toxicology and Carcinogenesis Studies of 1,3-Butadiene (CAS No. 106-99-0) in B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 May; 434():1-389. PubMed ID: 12616297
[TBL] [Abstract][Full Text] [Related]
29. Biomonitoring of 1,3-butadiene and related compounds.
Osterman-Golkar S; Bond JA
Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):907-15. PubMed ID: 8933033
[TBL] [Abstract][Full Text] [Related]
30. High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene.
Himmelstein MW; Asgharian B; Bond JA
Toxicol Appl Pharmacol; 1995 Jun; 132(2):281-8. PubMed ID: 7785055
[TBL] [Abstract][Full Text] [Related]
31. Hemoglobin adducts of epoxybutene in workers occupationally exposed to 1,3-butadiene.
Begemann P; Srám RJ; Neumann HG
Arch Toxicol; 2001 Jan; 74(11):680-7. PubMed ID: 11218044
[TBL] [Abstract][Full Text] [Related]
32. Somatic and germ cell effects in rats and mice after treatment with 1,3-butadiene and its metabolites, 1,2-epoxybutene and 1,2,3,4-diepoxybutane.
Anderson D; Dobrzyńka MM; Jackson LI; Yu TW; Brinkworth MH
Mutat Res; 1997 Jul; 391(3):233-42. PubMed ID: 9268048
[TBL] [Abstract][Full Text] [Related]
33. Biological monitoring of butadiene exposure by measurement of haemoglobin adducts.
Richardson KA; Megens HJ; Webb JD; van Sittert NJ
Toxicology; 1996 Oct; 113(1-3):112-8. PubMed ID: 8901890
[TBL] [Abstract][Full Text] [Related]
34. Inhalation pharmacokinetics of 1,2-epoxybutene-3 reveal species differences between rats and mice sensitive to butadiene-induced carcinogenesis.
Kreiling R; Laib RJ; Filser JG; Bolt HM
Arch Toxicol; 1987; 61(1):7-11. PubMed ID: 3439877
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the reactivity, regioselectivity, and stereoselectivity of the reactions of butadiene monoxide with valinamide and the N-terminal valine of mouse and rat hemoglobin.
Moll TS; Elfarra AA
Chem Res Toxicol; 1999 Aug; 12(8):679-89. PubMed ID: 10458701
[TBL] [Abstract][Full Text] [Related]
36. Measurement of plasma or urinary metabolites and Hprt mutant frequencies following inhalation exposure of mice and rats to 3-butene-1,2-diol.
Walker DM; McDonald JD; Meng Q; Kracko DA; Bauer MJ; Seilkop SK; Walker EL; Henderson RF; Walker VE
Chem Biol Interact; 2007 Mar; 166(1-3):191-206. PubMed ID: 17316587
[TBL] [Abstract][Full Text] [Related]
37. Molecular dosimetry of ethylene oxide: formation and persistence of N-(2-hydroxyethyl)valine in hemoglobin following repeated exposures of rats and mice.
Walker VE; MacNeela JP; Swenberg JA; Turner MJ; Fennell TR
Cancer Res; 1992 Aug; 52(16):4320-7. PubMed ID: 1643629
[TBL] [Abstract][Full Text] [Related]
38. 1,2:3,4-Diepoxybutane in blood of male B6C3F1 mice and male Sprague-Dawley rats exposed to 1,3-butadiene.
Csanády GA; Steinhoff R; Riester MB; Semder B; Pütz C; Li Q; Richter N; Kessler W; Klein D; Filser JG
Toxicol Lett; 2011 Dec; 207(3):286-90. PubMed ID: 21983653
[TBL] [Abstract][Full Text] [Related]
39. NTP technical report on the toxicity studies of Isoprene (CAS No. 78-79-5) Administered by Inhalation to F344/N Rats and B6C3F1 Mice.
Melnick R
Toxic Rep Ser; 1995 Jan; 31():1-G5. PubMed ID: 12209193
[TBL] [Abstract][Full Text] [Related]
40. Dosimetry by means of DNA and hemoglobin adducts in propylene oxide-exposed rats.
Osterman-Golkar S; Czene K; Lee MS; Faller TH; Csanády GA; Kessler W; Pérez HL; Filser JG; Segerbäck D
Toxicol Appl Pharmacol; 2003 Sep; 191(3):245-54. PubMed ID: 13678657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]